3//SEC Filing
Vida Ventures II, LLC 3
Accession 0001193125-26-008030
CIK 0002035832other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 8:41 PM ET
Size
12.3 KB
Accession
0001193125-26-008030
Insider Transaction Report
Form 3
Vida Ventures II, LLC
10% Owner
Holdings
- (indirect: See Footnote)
Series A Redeemable Convertible Preferred Stock
→ Common Stock (3,900,284 underlying) - (indirect: See Footnote)
Series A Redeemable Convertible Preferred Stock
→ Common Stock (108,229 underlying) - (indirect: See Footnote)
Series B Redeemable Convertible Preferred Stock
→ Common Stock (959,086 underlying) - (indirect: See Footnote)
Series B Redeemable Convertible Preferred Stock
→ Common Stock (26,613 underlying)
VIDA VENTURES II-A, LLC
10% Owner
Holdings
- (indirect: See Footnote)
Series A Redeemable Convertible Preferred Stock
→ Common Stock (3,900,284 underlying) - (indirect: See Footnote)
Series A Redeemable Convertible Preferred Stock
→ Common Stock (108,229 underlying) - (indirect: See Footnote)
Series B Redeemable Convertible Preferred Stock
→ Common Stock (959,086 underlying) - (indirect: See Footnote)
Series B Redeemable Convertible Preferred Stock
→ Common Stock (26,613 underlying)
Footnotes (4)
- [F1]Each share of Series A Redeemable Convertible Preferred Stock is convertible into shares of the Issuer's Common Stock on a 3.8044-for-1 basis and has no expiration date. All shares of Series A Redeemable Convertible Preferred Stock will automatically convert on a 3.8044-for-1 basis into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock without payment of additional consideration.
- [F2]These shares are held by Vida Ventures II, LLC ("VV II"). VV Manager II, LLC ("VVM II") is the manager of VV II and may be deemed to have voting, investment and dispositive power with respect to the shares held by VV II. Arie Belldegrun, Fred Cohen, and Leonard Potter, the members of the management committee of VVM II, along with the other members of the investment committee of VVM II, Rajul Jain, Joshua Kazam, and Helen Kim, a member of the Issuer's board of directors, may be deemed to share voting, investment and dispositive power over the shares held by VV II and each such person disclaims beneficial ownership of the securities except to the extent of such person's pecuniary interest therein.
- [F3]These shares are held by Vida Ventures II-A, LLC ("VV II-A"). VVM II is the manager of VV II-A and may be deemed to have voting, investment and dispositive power with respect to the shares held by VV II-A. Arie Belldegrun, Fred Cohen, and Leonard Potter, the members of the management committee of VVM II, along with the other members of the investment committee of VVM II, Rajul Jain, Joshua Kazam, and Helen Kim, a member of the Issuer's board of directors, may be deemed to share voting, investment and dispositive power over the shares held by VV II-A and each such person disclaims beneficial ownership of the securities except to the extent of such person's pecuniary interest therein.
- [F4]Each share of Series B Redeemable Convertible Preferred Stock is convertible into shares of the Issuer's Common Stock on a 3.8044-for-1 basis and has no expiration date. All shares of Series B Redeemable Convertible Preferred Stock will automatically convert on a 3.8044-for-1 basis into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock without payment of additional consideration.
Documents
Issuer
Aktis Oncology, Inc.
CIK 0002035832
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001776851
Filing Metadata
- Form type
- 3
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 8:41 PM ET
- Size
- 12.3 KB